Quotables
"Fooling around with alternating current is just a waste of time. Nobody will use it, ever."
Thomas Edison ; 1889
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7326255 | Use of latent pigments for high-remanence dyeing, composition containing the said pigments and processes using them The invention relates to the use, for dyeing keratin fibres, of at least one latent pigment, which is soluble in a medium that is suitable for dyeing, and which can be chemically, thermally or photochemically converted in the fibres into water-insoluble pigments, of... | 02/05/2008 |
| 7312336 | Compounds with analgesic effect Compounds of general formula (I) are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use ... | 12/25/2007 |
| 7294152 | Dyeing composition comprising at least one fluorindine compound for the dyeing of keratinic fibers, dyeing process comprising the composition and compound The present disclosure relates to a specific direct dye compound that is a fluorindine derivative, and dyeing compositions comprising at least one derivative of the compound and at least one polymer. A process for dyeing keratin fibers with the defined compositions ... | 11/13/2007 |
| 7232829 | Therapeutic compounds and methods The invention provides kappa receptor agonists of formula (I) and delta receptor antagonists of formula (II), wherein R1–R6 X and n have any of the meanings given in the specification, as well as compositions comprising them, methods for thei... | 06/19/2007 |
| 7164021 | Opiate analogs selective for the δ-opioid receptor Novel compounds which selectively bind to the δ-opioid receptor have been designed. These compounds have greater selectivity, improved water (blood) solubility, and enhanced therapeutic value as analgesics. Because agonists with selectivity for the δ-opioid recept... | 01/16/2007 |
| 6686470 | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof Compounds of the saframycin-ecteinascidin series with cytotoxic properties having the following general formula, their uses and synthesis, are disclosed: ##STR1## wherein R1 and R4 is H, a C1 to C4 alkyl group, ... | 02/03/2004 |
| 6586187 | Methods for solid phase combinatorial synthesis of integrin inhibitors Compounds of the formula ##STR1## are useful in the treatment of various disorders including, but not limited to, cancer (tumor metathesis, tumorgenesis/tumor growth), angiogenesis (as in cancer, diabetic retinopathy, rheumatoid arthritis), restenosis ... | 07/01/2003 |
| 6355783 | Compounds for mass coloration of high temperature polymers The invention relates to novel soluble pigment precursors possessing not only higher thermal stability but also improved solubility characteristics and to a process for mass coloration of high temperature polymers that utilizes these novel soluble pigment... | 03/12/2002 |
| 6222047 | Pyrocarbonic acid diesters and the preparation and use thereof The invention relates to the preparation of pyrocarbonic acid diesters by an improved process and to the novel pyrocarbonic acid diesters prepared according to said process as well as to the use thereof. The core of the invention is a process for the preparati... | 04/24/2001 |
| 5985876 | Nucleophile substituted ecteinascidins and N-oxide ecteinascidins Five new nucleophile substituted ecteinascidin (Et) compounds have been isolated from extracts of Ecteinascidia turbinata. These compounds have been purified by chromatographic techniques and their structures and bioactivities have been determined. The fi... | 11/16/1999 |
| 5788759 | δ-indanthrone blue pigment and manufacturing method therefor A δ-indanthrone blue pigment having an average primary particle diameter in the range of 0.5 μm or less and having a chroma C* value of 20 or greater; a hue angle in the range of 274-283 when colorimetry is performed on a paint film made from a melamine... | 08/04/1998 |
| 5561232 | Fluorescent quinacridone pigments Compounds of formula A(B)x, (I), wherein x is an integer from 1 to 4, A is the radical of a chromophore of the quinacridone, anthraquinone, perylene, indigo, quinophthalone, isoindolinone, isoindoline, dioxa... | 10/01/1996 |
| 5438050 | Indolocarbazole derivatives, processes for their preparation and compositions containing them New indolocarbazoles of formula: ##STR1## or a pharmaceutically acceptable salt thereof, processes for their preparation, compositions containing, and methods for using the composition for the inhibition of protein kinases, such as protein kinase ... | 08/01/1995 |
| 4816586 | Delta opioid receptor antagonists Delta-opioid receptor antagonists are disclosed of the formula: ##STR1## wherein R1 is (C1 -C5)alkyl, C3 -C6 (cycloalkyl)alkyl, C5 -C7 (cycloalkenyl)alkyl, aryl, aralkyl, tr... | 03/28/1989 |
| 4692189 | Novel compositions based on indanthrone blue pigments A composition comprising (a) an indanthrone blue pigment of formula I ##STR1## and (b) a sulfonated indanthrone blue derivative of formula II ##STR2## wherein X.sym. is H.sym. or a group of the formula Mn.sym. /... | 09/08/1987 |
| 4584381 | 5-(Nitro or halogen)-3-(alkyl)-2-(aminoalkyl)pyridines Compounds of the formula: ##STR1## where R1 is halogen or nitro; R2 is C1-4 alkyl; and R3 is a C1-3 alkylene group are intermediates to 2-(3,5-disubstituted pyridyl-alkyl amino)-5-pyridylmethyl-4... | 04/22/1986 |
| 4076713 | Indanthrene dyes A process for the preparation of a vat dye of the dianthraquinone-azine or dianthraquinone-N,N'-dihydroazine series, or a higher cyclic homologue thereof, which comprises reacting a primary amine selected from the group consisting of amino anthraquinones,... | 02/28/1978 |
